# meta::id = AMALGUM_academic_carbamazepine
# meta::title = Preparation and Evaluation of Carbamazepine Solid Lipid Nanoparticle for Alleviating Seizure Activity in Pentylenetetrazole-Kindled Mice
# meta::shortTitle = carbamazepine
# meta::author = Mona Qushawy, Kousalya Prabahar, Mohammed Abd-Alhaseeb, Shady Swidan, Ali Nasr
# meta::type = academic
# meta::dateCollected = 2019-11-03
# meta::sourceURL = https://www.mdpi.com/1420-3049/24/21/3971/htm
# meta::speakerList = none
# meta::speakerCount = 0
# newdoc id = AMALGUM_academic_carbamazepine
# sent_id = AMALGUM_academic_carbamazepine-1
# s_type = frag
# text = 1. Introduction
# newpar = head (1 s)
1	1.	1.	X	LS	_	2	dep	2:dep	Discourse=preparation:1->2
2	Introduction	introduction	NOUN	NN	Number=Sing	0	root	0:root	Entity=(abstract-1)

# sent_id = AMALGUM_academic_carbamazepine-2
# s_type = decl
# text = Epilepsy is a disorder in the central nervous system (CNS) that is characterized by an increase in the number of electrical impulses that occurs in one focal locus of the brain and/or the entire brain, resulting in partial or generalized seizures.
# newpar = p (1 s)
1	Epilepsy	epilepsy	NOUN	NN	Number=Sing	4	nsubj	4:nsubj	Discourse=ROOT:2|Entity=(abstract-2)
2	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	4	cop	4:cop	_
3	a	a	DET	DT	Definite=Ind|PronType=Art	4	det	4:det	Entity=(abstract-2
4	disorder	disorder	NOUN	NN	Number=Sing	0	root	0:root	_
5	in	in	ADP	IN	_	9	case	9:case	_
6	the	the	DET	DT	Definite=Def|PronType=Art	9	det	9:det	Entity=(abstract-3
7	central	central	ADJ	JJ	Degree=Pos	9	amod	9:amod	_
8	nervous	nervous	ADJ	JJ	Degree=Pos	9	amod	9:amod	_
9	system	system	NOUN	NN	Number=Sing	4	nmod	4:nmod:in|15:nsubj:pass	Entity=abstract-2)abstract-3)
10	(	(	PUNCT	-LRB-	_	11	punct	11:punct	Discourse=restatement:3->2|SpaceAfter=No
11	CNS	CNS	PROPN	NNP	Number=Sing	9	appos	9:appos	Entity=(abstract-3)|SpaceAfter=No
12	)	)	PUNCT	-RRB-	_	11	punct	11:punct	_
13	that	that	PRON	WDT	PronType=Rel	15	nsubj:pass	9:ref	Discourse=elaboration:4->2
14	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	15	aux:pass	15:aux:pass	_
15	characterized	characterize	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	9	acl:relcl	9:acl:relcl	_
16	by	by	ADP	IN	_	18	case	18:case	_
17	an	a	DET	DT	Definite=Ind|PronType=Art	18	det	18:det	Entity=(event-4
18	increase	increase	NOUN	NN	Number=Sing	15	obl	15:obl:by	_
19	in	in	ADP	IN	_	21	case	21:case	_
20	the	the	DET	DT	Definite=Def|PronType=Art	21	det	21:det	Entity=(abstract-5
21	number	number	NOUN	NN	Number=Sing	18	nmod	18:nmod:in	_
22	of	of	ADP	IN	_	24	case	24:case	_
23	electrical	electrical	ADJ	JJ	Degree=Pos	24	amod	24:amod	Entity=(abstract-6
24	impulses	impulse	NOUN	NNS	Number=Plur	21	nmod	21:nmod:of|26:nsubj	_
25	that	that	PRON	WDT	PronType=Rel	26	nsubj	24:ref	Discourse=elaboration:5->4
26	occurs	occur	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	24	acl:relcl	24:acl:relcl	_
27	in	in	ADP	IN	_	30	case	30:case	_
28	one	one	NUM	CD	NumForm=Word|NumType=Card	30	nummod	30:nummod	Entity=(abstract-7
29	focal	focal	ADJ	JJ	Degree=Pos	30	amod	30:amod	_
30	locus	locus	NOUN	NN	Number=Sing	26	obl	26:obl:in	_
31	of	of	ADP	IN	_	33	case	33:case	_
32	the	the	DET	DT	Definite=Def|PronType=Art	33	det	33:det	Entity=(object-8
33	brain	brain	NOUN	NN	Number=Sing	30	nmod	30:nmod:of	Entity=object-8)
34	and/or	and/or	CCONJ	CC	_	37	cc	37:cc	_
35	the	the	DET	DT	Definite=Def|PronType=Art	37	det	37:det	Entity=(object-9
36	entire	entire	ADJ	JJ	Degree=Pos	37	amod	37:amod	_
37	brain	brain	NOUN	NN	Number=Sing	33	conj	30:nmod:of|33:conj:and/or	Entity=event-4)abstract-5)abstract-6)abstract-7)object-9)|SpaceAfter=No
38	,	,	PUNCT	,	_	39	punct	39:punct	_
39	resulting	result	VERB	VBG	VerbForm=Ger	15	advcl	15:advcl	Discourse=elaboration:6->2
40	in	in	ADP	IN	_	44	case	44:case	_
41	partial	partial	ADJ	JJ	Degree=Pos	44	amod	44:amod	Entity=(event-10
42	or	or	CCONJ	CC	_	43	cc	43:cc	_
43	generalized	generalized	ADJ	JJ	Degree=Pos	41	conj	41:conj:or|44:amod	_
44	seizures	seizure	NOUN	NNS	Number=Plur	39	obl	39:obl:in	Entity=event-10)|SpaceAfter=No
45	.	.	PUNCT	.	_	4	punct	4:punct	_

# sent_id = AMALGUM_academic_carbamazepine-3
# s_type = decl
# text = The administration of antiepileptic drugs is mostly done via the oral or intravenous routes.
# newpar = p (5 s)
1	The	the	DET	DT	Definite=Def|PronType=Art	2	det	2:det	Discourse=elaboration:7->2|Entity=(event-11
2	administration	administration	NOUN	NN	Number=Sing	8	nsubj:pass	8:nsubj:pass	_
3	of	of	ADP	IN	_	5	case	5:case	_
4	antiepileptic	antiepileptic	ADJ	JJ	Degree=Pos	5	amod	5:amod	Entity=(substance-12
5	drugs	drug	NOUN	NNS	Number=Plur	2	nmod	2:nmod:of	Entity=event-11)substance-12)
6	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	8	aux:pass	8:aux:pass	_
7	mostly	mostly	ADV	RB	Degree=Pos	8	advmod	8:advmod	_
8	done	do	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
9	via	via	ADP	IN	_	14	case	14:case	_
10	the	the	DET	DT	Definite=Def|PronType=Art	14	det	14:det	Entity=(place-13
11	oral	oral	ADJ	JJ	Degree=Pos	14	amod	14:amod	_
12	or	or	CCONJ	CC	_	13	cc	13:cc	_
13	intravenous	intravenous	ADJ	JJ	Degree=Pos	11	conj	11:conj:or|14:amod	_
14	routes	route	NOUN	NNS	Number=Plur	8	obl	8:obl:via	Entity=place-13)|SpaceAfter=No
15	.	.	PUNCT	.	_	8	punct	8:punct	_

# sent_id = AMALGUM_academic_carbamazepine-4
# s_type = decl
# text = Drug resistance at the late stage of therapy develops in about 40% of patients.
1	Drug	drug	NOUN	NN	Number=Sing	2	compound	2:compound	Discourse=joint:8->7|Entity=(abstract-14(substance-15)
2	resistance	resistance	NOUN	NN	Number=Sing	9	nsubj	9:nsubj	_
3	at	at	ADP	IN	_	6	case	6:case	_
4	the	the	DET	DT	Definite=Def|PronType=Art	5	det	5:det	Entity=(time-16
5	late	late	ADJ	JJ	Degree=Pos	6	amod	6:amod	_
6	stage	stage	NOUN	NN	Number=Sing	2	nmod	2:nmod:at	_
7	of	of	ADP	IN	_	8	case	8:case	_
8	therapy	therapy	NOUN	NN	Number=Sing	6	nmod	6:nmod:of	Entity=abstract-14)time-16)(event-17)
9	develops	develop	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
10	in	in	ADP	IN	_	13	case	13:case	_
11	about	about	ADV	RB	_	12	advmod	12:advmod	Entity=(abstract-18
12	40	40	NUM	CD	NumForm=Digit|NumType=Card	13	nummod	13:nummod	SpaceAfter=No
13	%	%	SYM	NN	Number=Sing	9	obl	9:obl:in	_
14	of	of	ADP	IN	_	15	case	15:case	_
15	patients	patient	NOUN	NNS	Number=Plur	13	nmod	13:nmod:of	Entity=abstract-18)(person-19)|SpaceAfter=No
16	.	.	PUNCT	.	_	9	punct	9:punct	_

# sent_id = AMALGUM_academic_carbamazepine-5
# s_type = decl
# text = Drug resistance leads to uncontrolled seizures, a higher risk of brain damage, and increased mortality rates.
1	Drug	drug	NOUN	NN	Number=Sing	2	compound	2:compound	Discourse=joint:9->8|Entity=(abstract-14(substance-15)
2	resistance	resistance	NOUN	NN	Number=Sing	3	nsubj	3:nsubj	Entity=abstract-14)
3	leads	lead	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
4	to	to	ADP	IN	_	6	case	6:case	_
5	uncontrolled	uncontrolled	ADJ	JJ	Degree=Pos|Polarity=Neg	6	amod	6:amod	Entity=(event-10(event-10
6	seizures	seizure	NOUN	NNS	Number=Plur	3	obl	3:obl:to	Entity=event-10)|SpaceAfter=No
7	,	,	PUNCT	,	_	10	punct	10:punct	_
8	a	a	DET	DT	Definite=Ind|PronType=Art	10	det	10:det	Entity=(abstract-20
9	higher	high	ADJ	JJR	Degree=Cmp	10	amod	10:amod	_
10	risk	risk	NOUN	NN	Number=Sing	6	conj	3:obl:to|6:conj:and	_
11	of	of	ADP	IN	_	13	case	13:case	_
12	brain	brain	NOUN	NN	Number=Sing	13	compound	13:compound	Entity=(event-21(object-9)
13	damage	damage	NOUN	NN	Number=Sing	10	nmod	10:nmod:of	Entity=abstract-20)event-21)|SpaceAfter=No
14	,	,	PUNCT	,	_	18	punct	18:punct	_
15	and	and	CCONJ	CC	_	18	cc	18:cc	_
16	increased	increase	VERB	VBN	Tense=Past|VerbForm=Part	18	amod	18:amod	Entity=(abstract-22
17	mortality	mortality	NOUN	NN	Number=Sing	18	compound	18:compound	_
18	rates	rate	NOUN	NNS	Number=Plur	6	conj	3:obl:to|6:conj:and	Entity=event-10)abstract-22)|SpaceAfter=No
19	.	.	PUNCT	.	_	3	punct	3:punct	_

# sent_id = AMALGUM_academic_carbamazepine-6
# s_type = decl
# text = Patients with epilepsy suffer from emotional and behavioral changes, seizures, convulsions, muscular spasms, depression and, in some cases, unconsciousness.
1	Patients	patient	NOUN	NNS	Number=Plur	4	nsubj	4:nsubj	Discourse=elaboration:10->9|Entity=(person-19
2	with	with	ADP	IN	_	3	case	3:case	_
3	epilepsy	epilepsy	NOUN	NN	Number=Sing	1	nmod	1:nmod:with	Entity=person-19)(abstract-2)
4	suffer	suffer	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
5	from	from	ADP	IN	_	9	case	9:case	_
6	emotional	emotional	ADJ	JJ	Degree=Pos	9	amod	9:amod	Entity=(event-23
7	and	and	CCONJ	CC	_	8	cc	8:cc	_
8	behavioral	behavioral	ADJ	JJ	Degree=Pos	6	conj	6:conj:and|9:amod	_
9	changes	change	NOUN	NNS	Number=Plur	4	obl	4:obl:from	Entity=event-23)|SpaceAfter=No
10	,	,	PUNCT	,	_	11	punct	11:punct	_
11	seizures	seizure	NOUN	NNS	Number=Plur	9	conj	4:obl:from|9:conj:and	Entity=(event-10)|SpaceAfter=No
12	,	,	PUNCT	,	_	13	punct	13:punct	_
13	convulsions	convulsion	NOUN	NNS	Number=Plur	9	conj	4:obl:from|9:conj:and	Entity=(event-24)|SpaceAfter=No
14	,	,	PUNCT	,	_	16	punct	16:punct	_
15	muscular	muscular	ADJ	JJ	Degree=Pos	16	amod	16:amod	Entity=(event-25
16	spasms	spasm	NOUN	NNS	Number=Plur	9	conj	4:obl:from|9:conj:and	Entity=event-25)|SpaceAfter=No
17	,	,	PUNCT	,	_	18	punct	18:punct	_
18	depression	depression	NOUN	NN	Number=Sing	9	conj	4:obl:from|9:conj:and	Entity=(abstract-26)
19	and	and	CCONJ	CC	_	25	cc	25:cc	SpaceAfter=No
20	,	,	PUNCT	,	_	19	punct	19:punct	_
21	in	in	ADP	IN	_	23	case	23:case	_
22	some	some	DET	DT	_	23	det	23:det	Entity=(abstract-27(abstract-28
23	cases	case	NOUN	NNS	Number=Plur	25	nmod	25:nmod:in	Entity=abstract-28)|SpaceAfter=No
24	,	,	PUNCT	,	_	23	punct	23:punct	_
25	unconsciousness	unconsciousness	NOUN	NN	Number=Sing	9	conj	4:obl:from|9:conj:and	Entity=abstract-27)|SpaceAfter=No
26	.	.	PUNCT	.	_	4	punct	4:punct	_

# sent_id = AMALGUM_academic_carbamazepine-7
# s_type = decl
# text = Drugs used for the treatment of epilepsy have poor bioavailability and eventually become ineffective over the course of treatment due to drug resistance.
1	Drugs	drug	NOUN	NNS	Number=Plur	8	nsubj	8:nsubj|13:nsubj|14:nsubj:xsubj	Discourse=joint:11->10|Entity=(substance-12
2	used	use	VERB	VBN	Tense=Past|VerbForm=Part	1	acl	1:acl	Discourse=elaboration:12->11
3	for	for	ADP	IN	_	5	case	5:case	_
4	the	the	DET	DT	Definite=Def|PronType=Art	5	det	5:det	Entity=(event-29
5	treatment	treatment	NOUN	NN	Number=Sing	2	obl	2:obl:for	_
6	of	of	ADP	IN	_	7	case	7:case	_
7	epilepsy	epilepsy	NOUN	NN	Number=Sing	5	nmod	5:nmod:of	Entity=substance-12)event-29)(abstract-2)
8	have	have	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
9	poor	poor	ADJ	JJ	Degree=Pos	10	amod	10:amod	Entity=(abstract-30
10	bioavailability	bioavailability	NOUN	NN	Number=Sing	8	obj	8:obj	Entity=abstract-30)
11	and	and	CCONJ	CC	_	13	cc	13:cc	Discourse=joint:13->11
12	eventually	eventually	ADV	RB	Degree=Pos	13	advmod	13:advmod	_
13	become	become	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	8	conj	8:conj:and	_
14	ineffective	ineffective	ADJ	JJ	Degree=Pos	13	xcomp	13:xcomp	_
15	over	over	ADP	IN	_	17	case	17:case	_
16	the	the	DET	DT	Definite=Def|PronType=Art	17	det	17:det	Entity=(time-31
17	course	course	NOUN	NN	Number=Sing	14	obl	14:obl:over	_
18	of	of	ADP	IN	_	19	case	19:case	_
19	treatment	treatment	NOUN	NN	Number=Sing	17	nmod	17:nmod:of	Entity=time-31)(event-29)
20	due	due	ADJ	JJ	Degree=Pos	23	case	23:case	_
21	to	to	ADP	IN	_	20	fixed	20:fixed	_
22	drug	drug	NOUN	NN	Number=Sing	23	compound	23:compound	Entity=(abstract-14(substance-15)
23	resistance	resistance	NOUN	NN	Number=Sing	13	obl	13:obl:due_to	Entity=abstract-14)|SpaceAfter=No
24	.	.	PUNCT	.	_	8	punct	8:punct	_

# sent_id = AMALGUM_academic_carbamazepine-8
# s_type = decl
# text = Epilepsy treatment is often complicated due to the poor release of the drug through the adjunctive blood–brain barrier, which may be overcome by the preparation of the drug as solid lipid nanoparticles.
# newpar = p (2 s)
1	Epilepsy	epilepsy	NOUN	NN	Number=Sing	2	compound	2:compound	Discourse=joint:14->9|Entity=(event-29(abstract-2)
2	treatment	treatment	NOUN	NN	Number=Sing	5	nsubj:pass	5:nsubj:pass	Entity=event-29)
3	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	5	aux:pass	5:aux:pass	_
4	often	often	ADV	RB	Degree=Pos	5	advmod	5:advmod	_
5	complicated	complicate	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
6	due	due	ADJ	JJ	Degree=Pos	10	case	10:case	_
7	to	to	ADP	IN	_	6	fixed	6:fixed	_
8	the	the	DET	DT	Definite=Def|PronType=Art	10	det	10:det	Entity=(event-32
9	poor	poor	ADJ	JJ	Degree=Pos	10	amod	10:amod	_
10	release	release	NOUN	NN	Number=Sing	5	obl	5:obl:due_to|25:nsubj:pass	_
11	of	of	ADP	IN	_	13	case	13:case	_
12	the	the	DET	DT	Definite=Def|PronType=Art	13	det	13:det	Entity=(substance-15
13	drug	drug	NOUN	NN	Number=Sing	10	nmod	10:nmod:of	Entity=substance-15)
14	through	through	ADP	IN	_	20	case	20:case	_
15	the	the	DET	DT	Definite=Def|PronType=Art	20	det	20:det	Entity=(object-33
16	adjunctive	adjunctive	ADJ	JJ	Degree=Pos	20	amod	20:amod	_
17	blood	blood	NOUN	NN	Number=Sing	20	compound	20:compound	Entity=(substance-34)|SpaceAfter=No
18	–	-	SYM	SYM	_	19	cc	19:cc	SpaceAfter=No
19	brain	brain	NOUN	NN	Number=Sing	17	conj	17:conj:to|20:compound	Entity=(object-9)
20	barrier	barrier	NOUN	NN	Number=Sing	10	nmod	10:nmod:through	Entity=object-33)|SpaceAfter=No
21	,	,	PUNCT	,	_	25	punct	25:punct	_
22	which	which	PRON	WDT	PronType=Rel	25	nsubj:pass	10:ref	Discourse=elaboration:15->14
23	may	may	AUX	MD	VerbForm=Fin	25	aux	25:aux	_
24	be	be	AUX	VB	VerbForm=Inf	25	aux:pass	25:aux:pass	_
25	overcome	overcome	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	10	acl:relcl	10:acl:relcl	_
26	by	by	ADP	IN	_	28	case	28:case	_
27	the	the	DET	DT	Definite=Def|PronType=Art	28	det	28:det	Entity=(event-35
28	preparation	preparation	NOUN	NN	Number=Sing	25	obl	25:obl:by	_
29	of	of	ADP	IN	_	31	case	31:case	_
30	the	the	DET	DT	Definite=Def|PronType=Art	31	det	31:det	Entity=(substance-15
31	drug	drug	NOUN	NN	Number=Sing	28	nmod	28:nmod:of	Entity=event-35)substance-15)
32	as	as	ADP	IN	_	35	case	35:case	_
33	solid	solid	ADJ	JJ	Degree=Pos	35	amod	35:amod	Entity=(object-36
34	lipid	lipid	NOUN	NN	Number=Sing	35	compound	35:compound	Entity=(substance-37)
35	nanoparticles	nanoparticle	NOUN	NNS	Number=Plur	25	obl	25:obl:as	Entity=event-32)object-36)|SpaceAfter=No
36	.	.	PUNCT	.	_	5	punct	5:punct	_

# sent_id = AMALGUM_academic_carbamazepine-9
# s_type = decl
# text = The ideal delivery systems of antiepileptic drugs are the ones which provide localized and controlled drug release to targeted sites in the brain, which helps to reduce drug-associated toxicities and enhances the efficacy of the drug.
1	The	the	DET	DT	Definite=Def|PronType=Art	4	det	4:det	Discourse=elaboration:16->14|Entity=(object-38
2	ideal	ideal	ADJ	JJ	Degree=Pos	4	amod	4:amod	_
3	delivery	delivery	NOUN	NN	Number=Sing	4	compound	4:compound	Entity=(abstract-39)
4	systems	system	NOUN	NNS	Number=Plur	10	nsubj	10:nsubj	_
5	of	of	ADP	IN	_	7	case	7:case	_
6	antiepileptic	antiepileptic	ADJ	JJ	Degree=Pos	7	amod	7:amod	Entity=(substance-12
7	drugs	drug	NOUN	NNS	Number=Plur	4	nmod	4:nmod:of	Entity=object-38)substance-12)
8	are	be	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	10	cop	10:cop	_
9	the	the	DET	DT	Definite=Def|PronType=Art	10	det	10:det	Entity=(object-38
10	ones	one	NOUN	NNS	Number=Plur	0	root	0:root|12:nsubj	_
11	which	which	PRON	WDT	PronType=Rel	12	nsubj	10:ref	Discourse=elaboration:17->16
12	provide	provide	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	10	acl:relcl	10:acl:relcl	_
13	localized	localize	VERB	VBN	Tense=Past|VerbForm=Part	17	amod	17:amod	Entity=(event-32
14	and	and	CCONJ	CC	_	15	cc	15:cc	_
15	controlled	control	VERB	VBN	Tense=Past|VerbForm=Part	13	conj	13:conj:and|17:amod	_
16	drug	drug	NOUN	NN	Number=Sing	17	compound	17:compound	Entity=(substance-15)
17	release	release	NOUN	NN	Number=Sing	12	obj	12:obj|26:nsubj	_
18	to	to	ADP	IN	_	20	case	20:case	_
19	targeted	target	VERB	VBN	Tense=Past|VerbForm=Part	20	amod	20:amod	Entity=(place-40
20	sites	site	NOUN	NNS	Number=Plur	12	obl	12:obl:to	_
21	in	in	ADP	IN	_	23	case	23:case	_
22	the	the	DET	DT	Definite=Def|PronType=Art	23	det	23:det	Entity=(object-9
23	brain	brain	NOUN	NN	Number=Sing	20	nmod	20:nmod:in	Entity=place-40)object-9)|SpaceAfter=No
24	,	,	PUNCT	,	_	26	punct	26:punct	_
25	which	which	PRON	WDT	PronType=Rel	26	nsubj	17:ref	Discourse=elaboration:18->16
26	helps	help	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	17	acl:relcl	17:acl:relcl	_
27	to	to	PART	TO	_	28	mark	28:mark	_
28	reduce	reduce	VERB	VB	VerbForm=Inf	26	xcomp	26:xcomp	_
29	drug-associated	drug-associated	ADJ	JJ	Degree=Pos	30	amod	30:amod	Entity=(abstract-41
30	toxicities	toxicity	NOUN	NNS	Number=Plur	28	obj	28:obj	Entity=abstract-41)
31	and	and	CCONJ	CC	_	32	cc	32:cc	Discourse=joint:19->18
32	enhances	enhance	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	28	conj	26:xcomp|28:conj:and	_
33	the	the	DET	DT	Definite=Def|PronType=Art	34	det	34:det	Entity=(abstract-42
34	efficacy	efficacy	NOUN	NN	Number=Sing	32	obj	32:obj	_
35	of	of	ADP	IN	_	37	case	37:case	_
36	the	the	DET	DT	Definite=Def|PronType=Art	37	det	37:det	Entity=(substance-15
37	drug	drug	NOUN	NN	Number=Sing	34	nmod	34:nmod:of	Entity=object-38)event-32)abstract-42)substance-15)|SpaceAfter=No
38	.	.	PUNCT	.	_	10	punct	10:punct	_

# sent_id = AMALGUM_academic_carbamazepine-10
# s_type = decl
# text = Carbamazepine (CBZ) is an antiepileptic drug with a narrow therapeutic index, and it is poorly absorbed when taken by the oral route.
# newpar = p (3 s)
1	Carbamazepine	Carbamazepine	PROPN	NNP	Number=Sing	8	nsubj	8:nsubj	Discourse=joint:20->16|Entity=(substance-43)
2	(	(	PUNCT	-LRB-	_	3	punct	3:punct	Discourse=restatement:21->20|SpaceAfter=No
3	CBZ	CBZ	PROPN	NNP	Number=Sing	1	appos	1:appos	Entity=(abstract-44)|SpaceAfter=No
4	)	)	PUNCT	-RRB-	_	3	punct	3:punct	_
5	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	8	cop	8:cop	Discourse=same_unit:22->20
6	an	a	DET	DT	Definite=Ind|PronType=Art	8	det	8:det	Entity=(substance-43
7	antiepileptic	antiepileptic	ADJ	JJ	Degree=Pos	8	amod	8:amod	_
8	drug	drug	NOUN	NN	Number=Sing	0	root	0:root	_
9	with	with	ADP	IN	_	13	case	13:case	_
10	a	a	DET	DT	Definite=Ind|PronType=Art	13	det	13:det	Entity=(abstract-45
11	narrow	narrow	ADJ	JJ	Degree=Pos	13	amod	13:amod	_
12	therapeutic	therapeutic	ADJ	JJ	Degree=Pos	13	amod	13:amod	_
13	index	index	NOUN	NN	Number=Sing	8	nmod	8:nmod:with	Entity=substance-43)abstract-45)|SpaceAfter=No
14	,	,	PUNCT	,	_	19	punct	19:punct	_
15	and	and	CCONJ	CC	_	19	cc	19:cc	Discourse=joint:23->20
16	it	it	PRON	PRP	Case=Nom|Gender=Neut|Number=Sing|Person=3|PronType=Prs	19	nsubj:pass	19:nsubj:pass	Entity=(abstract-45)
17	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	19	aux:pass	19:aux:pass	_
18	poorly	poorly	ADV	RB	Degree=Pos	19	advmod	19:advmod	_
19	absorbed	absorb	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	8	conj	8:conj:and	_
20	when	when	SCONJ	WRB	PronType=Int	21	mark	21:mark	Discourse=circumstance:24->23
21	taken	take	VERB	VBN	Tense=Past|VerbForm=Part	19	advcl	19:advcl:when	_
22	by	by	ADP	IN	_	25	case	25:case	_
23	the	the	DET	DT	Definite=Def|PronType=Art	25	det	25:det	Entity=(abstract-46
24	oral	oral	ADJ	JJ	Degree=Pos	25	amod	25:amod	_
25	route	route	NOUN	NN	Number=Sing	21	obl	21:obl:by	Entity=abstract-46)|SpaceAfter=No
26	.	.	PUNCT	.	_	8	punct	8:punct	_

# sent_id = AMALGUM_academic_carbamazepine-11
# s_type = decl
# text = Its oral bioavailability is 75%, and its maximum achieved plasma concentration is about 4–8 h after administration.
1	Its	its	PRON	PRP$	Gender=Neut|Number=Sing|Person=3|Poss=Yes|PronType=Prs	3	nmod:poss	3:nmod:poss	Discourse=joint:25->20|Entity=(abstract-30(substance-43)
2	oral	oral	ADJ	JJ	Degree=Pos	3	amod	3:amod	_
3	bioavailability	bioavailability	NOUN	NN	Number=Sing	6	nsubj	6:nsubj	Entity=abstract-30)
4	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	6	cop	6:cop	_
5	75	75	NUM	CD	NumForm=Digit|NumType=Card	6	nummod	6:nummod	Entity=(abstract-30(abstract-30|SpaceAfter=No
6	%	%	SYM	NN	Number=Sing	0	root	0:root	Entity=abstract-30)|SpaceAfter=No
7	,	,	PUNCT	,	_	19	punct	19:punct	_
8	and	and	CCONJ	CC	_	19	cc	19:cc	Discourse=joint:26->25
9	its	its	PRON	PRP$	Gender=Neut|Number=Sing|Person=3|Poss=Yes|PronType=Prs	13	nmod:poss	13:nmod:poss	Entity=(abstract-47(substance-43)
10	maximum	maximum	ADJ	JJ	Degree=Pos	13	amod	13:amod	_
11	achieved	achieve	VERB	VBN	Tense=Past|VerbForm=Part	13	amod	13:amod	_
12	plasma	plasma	NOUN	NN	Number=Sing	13	compound	13:compound	Entity=(substance-48)
13	concentration	concentration	NOUN	NN	Number=Sing	19	nsubj	19:nsubj	Entity=abstract-47)
14	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	19	cop	19:cop	_
15	about	about	ADV	RB	_	16	advmod	16:advmod	Entity=(abstract-47
16	4	4	NUM	CD	NumForm=Digit|NumType=Card	19	nummod	19:nummod	SpaceAfter=No
17	–	-	SYM	SYM	_	18	case	18:case	SpaceAfter=No
18	8	8	NUM	CD	NumForm=Digit|NumType=Card	16	nmod	16:nmod:to	_
19	h	hour	NOUN	NN	Number=Sing	6	conj	6:conj:and	_
20	after	after	ADP	IN	_	21	case	21:case	_
21	administration	administration	NOUN	NN	Number=Sing	19	nmod	19:nmod:after	Entity=abstract-30)abstract-47)(event-11)|SpaceAfter=No
22	.	.	PUNCT	.	_	6	punct	6:punct	_

# sent_id = AMALGUM_academic_carbamazepine-12
# s_type = decl
# text = Carbamazepine acts through the inactivation of sodium channels, making brain cells less excitable.
1	Carbamazepine	carbamazepine	NOUN	NN	Number=Sing	2	nsubj	2:nsubj	Discourse=joint:27->25|Entity=(substance-43)
2	acts	act	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
3	through	through	ADP	IN	_	5	case	5:case	_
4	the	the	DET	DT	Definite=Def|PronType=Art	5	det	5:det	Entity=(event-49
5	inactivation	inactivation	NOUN	NN	Number=Sing	2	obl	2:obl:through	_
6	of	of	ADP	IN	_	8	case	8:case	_
7	sodium	sodium	NOUN	NN	Number=Sing	8	compound	8:compound	Entity=(object-50(substance-51)
8	channels	channel	NOUN	NNS	Number=Plur	5	nmod	5:nmod:of	Entity=event-49)object-50)|SpaceAfter=No
9	,	,	PUNCT	,	_	10	punct	10:punct	_
10	making	make	VERB	VBG	VerbForm=Ger	2	advcl	2:advcl	Discourse=result:28->27
11	brain	brain	NOUN	NN	Number=Sing	12	compound	12:compound	Entity=(animal-52(object-9)
12	cells	cell	NOUN	NNS	Number=Plur	10	obj	10:obj|14:nsubj:xsubj	Entity=animal-52)
13	less	less	ADV	RBR	Degree=Cmp	14	advmod	14:advmod	_
14	excitable	excitable	ADJ	JJ	Degree=Pos	10	xcomp	10:xcomp	SpaceAfter=No
15	.	.	PUNCT	.	_	2	punct	2:punct	_

# sent_id = AMALGUM_academic_carbamazepine-13
# s_type = decl
# text = Solid lipid nanoparticles (SLNs) are considered an alternative to colloidal systems like liposome, noisome and polymeric nanoparticles.
# newpar = p (2 s)
1	Solid	solid	ADJ	JJ	Degree=Pos	3	amod	3:amod	Discourse=joint:29->27|Entity=(object-36
2	lipid	lipid	NOUN	NN	Number=Sing	3	compound	3:compound	Entity=(substance-37)
3	nanoparticles	nanoparticle	NOUN	NNS	Number=Plur	8	nsubj:pass	8:nsubj:pass|10:nsubj:xsubj	Entity=object-36)
4	(	(	PUNCT	-LRB-	_	5	punct	5:punct	Discourse=restatement:30->29|SpaceAfter=No
5	SLNs	SLN	NOUN	NNS	Number=Plur	3	appos	3:appos	Entity=(abstract-53)|SpaceAfter=No
6	)	)	PUNCT	-RRB-	_	5	punct	5:punct	_
7	are	be	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	8	aux:pass	8:aux:pass	Discourse=same_unit:31->29
8	considered	consider	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
9	an	a	DET	DT	Definite=Ind|PronType=Art	10	det	10:det	Entity=(abstract-54
10	alternative	alternative	NOUN	NN	Number=Sing	8	xcomp	8:xcomp	_
11	to	to	ADP	IN	_	13	case	13:case	_
12	colloidal	colloidal	ADJ	JJ	Degree=Pos	13	amod	13:amod	Entity=(object-38
13	systems	system	NOUN	NNS	Number=Plur	10	nmod	10:nmod:to	_
14	like	like	ADP	IN	_	15	case	15:case	_
15	liposome	liposome	NOUN	NN	Number=Sing	13	nmod	13:nmod:like	Entity=(substance-55)|SpaceAfter=No
16	,	,	PUNCT	,	_	17	punct	17:punct	_
17	noisome	noisome	NOUN	NN	Number=Sing	15	conj	13:nmod:like|15:conj:and	Entity=(abstract-56)
18	and	and	CCONJ	CC	_	20	cc	20:cc	_
19	polymeric	polymeric	ADJ	JJ	Degree=Pos	20	amod	20:amod	Entity=(object-36
20	nanoparticles	nanoparticle	NOUN	NNS	Number=Plur	15	conj	13:nmod:like|15:conj:and	Entity=abstract-54)object-38)object-36)|SpaceAfter=No
21	.	.	PUNCT	.	_	8	punct	8:punct	_

# sent_id = AMALGUM_academic_carbamazepine-14
# s_type = decl
# text = SLNs consist of solid lipids, which act as a stabilizer when dispersed in water in the presence of a surfactant.
1	SLNs	SLN	NOUN	NNS	Number=Plur	2	nsubj	2:nsubj	Discourse=joint:32->29|Entity=(abstract-53)
2	consist	consist	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
3	of	of	ADP	IN	_	5	case	5:case	_
4	solid	solid	ADJ	JJ	Degree=Pos	5	amod	5:amod	Entity=(substance-57
5	lipids	lipid	NOUN	NNS	Number=Plur	2	obl	2:obl:of|8:nsubj	SpaceAfter=No
6	,	,	PUNCT	,	_	8	punct	8:punct	_
7	which	which	PRON	WDT	PronType=Rel	8	nsubj	5:ref	Discourse=elaboration:33->32
8	act	act	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	5	acl:relcl	5:acl:relcl	_
9	as	as	ADP	IN	_	11	case	11:case	_
10	a	a	DET	DT	Definite=Ind|PronType=Art	11	det	11:det	Entity=(object-58
11	stabilizer	stabilizer	NOUN	NN	Number=Sing	8	obl	8:obl:as	Entity=substance-57)object-58)
12	when	when	SCONJ	WRB	PronType=Int	13	mark	13:mark	Discourse=circumstance:34->33
13	dispersed	disperse	VERB	VBN	Tense=Past|VerbForm=Part	8	advcl	8:advcl:when	_
14	in	in	ADP	IN	_	15	case	15:case	_
15	water	water	NOUN	NN	Number=Sing	13	obl	13:obl:in	Entity=(substance-59)
16	in	in	ADP	IN	_	18	case	18:case	_
17	the	the	DET	DT	Definite=Def|PronType=Art	18	det	18:det	Entity=(abstract-60
18	presence	presence	NOUN	NN	Number=Sing	13	obl	13:obl:in	_
19	of	of	ADP	IN	_	21	case	21:case	_
20	a	a	DET	DT	Definite=Ind|PronType=Art	21	det	21:det	Entity=(substance-61
21	surfactant	surfactant	NOUN	NN	Number=Sing	18	nmod	18:nmod:of	Entity=abstract-60)substance-61)|SpaceAfter=No
22	.	.	PUNCT	.	_	2	punct	2:punct	_

# sent_id = AMALGUM_academic_carbamazepine-15
# s_type = decl
# text = SLN is characterized by its small size (nano range), large surface area, and high drug loading capacity.
# newpar = p (5 s)
1	SLN	SLN	PROPN	NNP	Number=Sing	3	nsubj:pass	3:nsubj:pass	Discourse=joint:35->32|Entity=(abstract-62)
2	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	3	aux:pass	3:aux:pass	_
3	characterized	characterize	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
4	by	by	ADP	IN	_	7	case	7:case	_
5	its	its	PRON	PRP$	Gender=Neut|Number=Sing|Person=3|Poss=Yes|PronType=Prs	7	nmod:poss	7:nmod:poss	Entity=(abstract-63(abstract-62)
6	small	small	ADJ	JJ	Degree=Pos	7	amod	7:amod	_
7	size	size	NOUN	NN	Number=Sing	3	obl	3:obl:by	Entity=abstract-63)
8	(	(	PUNCT	-LRB-	_	10	punct	10:punct	Discourse=elaboration:36->35|SpaceAfter=No
9	nano	nano	NOUN	NN	Number=Sing	10	compound	10:compound	Entity=(abstract-63(object-64)
10	range	range	NOUN	NN	Number=Sing	7	appos	7:appos	Entity=abstract-63)|SpaceAfter=No
11	)	)	PUNCT	-RRB-	_	10	punct	10:punct	SpaceAfter=No
12	,	,	PUNCT	,	_	15	punct	15:punct	_
13	large	large	ADJ	JJ	Degree=Pos	15	amod	15:amod	Entity=(abstract-65
14	surface	surface	NOUN	NN	Number=Sing	15	compound	15:compound	Entity=(place-66)
15	area	area	NOUN	NN	Number=Sing	7	conj	3:obl:by|7:conj:and	Entity=abstract-65)|SpaceAfter=No
16	,	,	PUNCT	,	_	21	punct	21:punct	_
17	and	and	CCONJ	CC	_	21	cc	21:cc	_
18	high	high	ADJ	JJ	Degree=Pos	21	amod	21:amod	Entity=(abstract-67
19	drug	drug	NOUN	NN	Number=Sing	20	compound	20:compound	Entity=(abstract-68(substance-43)
20	loading	loading	NOUN	NN	Number=Sing	21	compound	21:compound	Entity=abstract-68)
21	capacity	capacity	NOUN	NN	Number=Sing	7	conj	3:obl:by|7:conj:and	Entity=abstract-67)|SpaceAfter=No
22	.	.	PUNCT	.	_	3	punct	3:punct	_

# sent_id = AMALGUM_academic_carbamazepine-16
# s_type = decl
# text = In addition, it improves drug stability and has the ability to improve the oral bioavailability of poorly water-soluble drugs.
1	In	in	ADP	IN	_	2	case	2:case	Discourse=joint:37->35
2	addition	addition	NOUN	NN	Number=Sing	5	obl	5:obl:in	SpaceAfter=No
3	,	,	PUNCT	,	_	2	punct	2:punct	_
4	it	it	PRON	PRP	Case=Nom|Gender=Neut|Number=Sing|Person=3|PronType=Prs	5	nsubj	5:nsubj|9:nsubj	Entity=(abstract-67)
5	improves	improve	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
6	drug	drug	NOUN	NN	Number=Sing	7	compound	7:compound	Entity=(abstract-69(substance-43)
7	stability	stability	NOUN	NN	Number=Sing	5	obj	5:obj	Entity=abstract-69)
8	and	and	CCONJ	CC	_	9	cc	9:cc	Discourse=joint:38->37
9	has	have	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	5	conj	5:conj:and	_
10	the	the	DET	DT	Definite=Def|PronType=Art	11	det	11:det	Entity=(abstract-67
11	ability	ability	NOUN	NN	Number=Sing	9	obj	9:obj	_
12	to	to	PART	TO	_	13	mark	13:mark	Discourse=purpose:39->38
13	improve	improve	VERB	VB	VerbForm=Inf	11	acl	11:acl:to	_
14	the	the	DET	DT	Definite=Def|PronType=Art	16	det	16:det	Entity=(abstract-30
15	oral	oral	ADJ	JJ	Degree=Pos	16	amod	16:amod	_
16	bioavailability	bioavailability	NOUN	NN	Number=Sing	13	obj	13:obj	_
17	of	of	ADP	IN	_	20	case	20:case	_
18	poorly	poorly	ADV	RB	Degree=Pos	19	advmod	19:advmod	Entity=(substance-12
19	water-soluble	water-soluble	ADJ	JJ	Degree=Pos	20	amod	20:amod	_
20	drugs	drug	NOUN	NNS	Number=Plur	16	nmod	16:nmod:of	Entity=abstract-67)abstract-30)substance-12)|SpaceAfter=No
21	.	.	PUNCT	.	_	5	punct	5:punct	_

# sent_id = AMALGUM_academic_carbamazepine-17
# s_type = decl
# text = Gangurde and Kumar prepared lamotrigine solid lipid nanoparticles with a high efficacy for treatment of epilepsy.
1	Gangurde	Gangurde	PROPN	NNP	Number=Sing	4	nsubj	4:nsubj	Discourse=joint:40->35|Entity=(person-70)
2	and	and	CCONJ	CC	_	3	cc	3:cc	_
3	Kumar	Kumar	PROPN	NNP	Number=Sing	1	conj	1:conj:and|4:nsubj	Entity=(person-71)
4	prepared	prepare	VERB	VBD	Mood=Ind|Number=Plur|Person=3|Tense=Past|VerbForm=Fin	0	root	0:root	_
5	lamotrigine	lamotrigine	NOUN	NN	Number=Sing	8	compound	8:compound	Entity=(object-36(object-72)
6	solid	solid	ADJ	JJ	Degree=Pos	8	amod	8:amod	_
7	lipid	lipid	NOUN	NN	Number=Sing	8	compound	8:compound	Entity=(substance-37)
8	nanoparticles	nanoparticle	NOUN	NNS	Number=Plur	4	obj	4:obj	Entity=object-36)
9	with	with	ADP	IN	_	12	case	12:case	_
10	a	a	DET	DT	Definite=Ind|PronType=Art	12	det	12:det	Entity=(abstract-42
11	high	high	ADJ	JJ	Degree=Pos	12	amod	12:amod	_
12	efficacy	efficacy	NOUN	NN	Number=Sing	4	obl	4:obl:with	_
13	for	for	ADP	IN	_	14	case	14:case	_
14	treatment	treatment	NOUN	NN	Number=Sing	12	nmod	12:nmod:for	Entity=(abstract-73
15	of	of	ADP	IN	_	16	case	16:case	_
16	epilepsy	epilepsy	NOUN	NN	Number=Sing	14	nmod	14:nmod:of	Entity=abstract-42)abstract-73)(abstract-2)|SpaceAfter=No
17	.	.	PUNCT	.	_	4	punct	4:punct	_

# sent_id = AMALGUM_academic_carbamazepine-18
# s_type = decl
# text = Nair et al. prepared carbamazepine solid lipid nanoparticles to improve its therapeutic effect.
1	Nair	Nair	PROPN	NNP	Number=Sing	4	nsubj	4:nsubj	Discourse=elaboration:41->40|Entity=(person-74)
2	et	et	X	FW	_	3	cc	3:cc	_
3	al.	al.	X	FW	Abbr=Yes	1	conj	1:conj:et|4:nsubj	_
4	prepared	prepare	VERB	VBD	Mood=Ind|Number=Plur|Person=3|Tense=Past|VerbForm=Fin	0	root	0:root	_
5	carbamazepine	carbamazepine	NOUN	NN	Number=Sing	8	compound	8:compound	Entity=(object-36(substance-43)
6	solid	solid	ADJ	JJ	Degree=Pos	8	amod	8:amod	_
7	lipid	lipid	NOUN	NN	Number=Sing	8	compound	8:compound	Entity=(substance-37)
8	nanoparticles	nanoparticle	NOUN	NNS	Number=Plur	4	obj	4:obj	Entity=object-36)
9	to	to	PART	TO	_	10	mark	10:mark	Discourse=purpose:42->41
10	improve	improve	VERB	VB	VerbForm=Inf	4	advcl	4:advcl:to	_
11	its	its	PRON	PRP$	Gender=Neut|Number=Sing|Person=3|Poss=Yes|PronType=Prs	13	nmod:poss	13:nmod:poss	Entity=(abstract-75(abstract-2)
12	therapeutic	therapeutic	ADJ	JJ	Degree=Pos	13	amod	13:amod	_
13	effect	effect	NOUN	NN	Number=Sing	10	obj	10:obj	Entity=abstract-75)|SpaceAfter=No
14	.	.	PUNCT	.	_	4	punct	4:punct	_

# sent_id = AMALGUM_academic_carbamazepine-19
# s_type = decl
# text = Kumar et al. prepared solid lipid nanoparticles of methylthioadenosine for the management of neurological conditions via oral delivery.
1	Kumar	Kumar	PROPN	NNP	Number=Sing	4	nsubj	4:nsubj	Discourse=joint:43->41|Entity=(person-71)
2	et	et	X	FW	_	3	cc	3:cc	_
3	al.	al.	X	FW	Abbr=Yes	1	conj	1:conj:et|4:nsubj	_
4	prepared	prepare	VERB	VBD	Mood=Ind|Number=Plur|Person=3|Tense=Past|VerbForm=Fin	0	root	0:root	_
5	solid	solid	ADJ	JJ	Degree=Pos	7	amod	7:amod	Entity=(object-36
6	lipid	lipid	NOUN	NN	Number=Sing	7	compound	7:compound	Entity=(substance-37)
7	nanoparticles	nanoparticle	NOUN	NNS	Number=Plur	4	obj	4:obj	_
8	of	of	ADP	IN	_	9	case	9:case	_
9	methylthioadenosine	methylthioadenosine	NOUN	NN	Number=Sing	7	nmod	7:nmod:of	Entity=object-36)(abstract-76)
10	for	for	ADP	IN	_	12	case	12:case	_
11	the	the	DET	DT	Definite=Def|PronType=Art	12	det	12:det	Entity=(organization-77
12	management	management	NOUN	NN	Number=Sing	4	obl	4:obl:for	_
13	of	of	ADP	IN	_	15	case	15:case	_
14	neurological	neurological	ADJ	JJ	Degree=Pos	15	amod	15:amod	Entity=(abstract-78
15	conditions	condition	NOUN	NNS	Number=Plur	12	nmod	12:nmod:of	Entity=abstract-78)
16	via	via	ADP	IN	_	18	case	18:case	_
17	oral	oral	ADJ	JJ	Degree=Pos	18	amod	18:amod	Entity=(abstract-39
18	delivery	delivery	NOUN	NN	Number=Sing	12	nmod	12:nmod:via	Entity=organization-77)abstract-39)|SpaceAfter=No
19	.	.	PUNCT	.	_	4	punct	4:punct	_

# sent_id = AMALGUM_academic_carbamazepine-20
# s_type = decl
# text = The objective of the current study was to prepare carbamazepine solid lipid nanoparticles (CBZ-SLNs) as a novel and alternative method for other colloidal dispersion carriers.
# newpar = p (2 s)
1	The	the	DET	DT	Definite=Def|PronType=Art	2	det	2:det	Discourse=elaboration:44->43|Entity=(abstract-79
2	objective	objective	NOUN	NN	Number=Sing	9	nsubj	9:nsubj	_
3	of	of	ADP	IN	_	6	case	6:case	_
4	the	the	DET	DT	Definite=Def|PronType=Art	6	det	6:det	Entity=(abstract-80
5	current	current	ADJ	JJ	Degree=Pos	6	amod	6:amod	_
6	study	study	NOUN	NN	Number=Sing	2	nmod	2:nmod:of	Entity=abstract-79)abstract-80)
7	was	be	AUX	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	9	cop	9:cop	_
8	to	to	PART	TO	_	9	mark	9:mark	_
9	prepare	prepare	VERB	VB	VerbForm=Inf	0	root	0:root	_
10	carbamazepine	carbamazepine	NOUN	NN	Number=Sing	13	compound	13:compound	Entity=(object-36(substance-43)
11	solid	solid	ADJ	JJ	Degree=Pos	13	amod	13:amod	_
12	lipid	lipid	NOUN	NN	Number=Sing	13	compound	13:compound	Entity=(substance-37)
13	nanoparticles	nanoparticle	NOUN	NNS	Number=Plur	9	obj	9:obj	Entity=object-36)
14	(	(	PUNCT	-LRB-	_	15	punct	15:punct	Discourse=restatement:45->44|SpaceAfter=No
15	CBZ-SLNs	CBz-SLNs	PROPN	NNP	Number=Sing	13	appos	13:appos	Entity=(abstract-81)|SpaceAfter=No
16	)	)	PUNCT	-RRB-	_	15	punct	15:punct	_
17	as	as	ADP	IN	_	22	case	22:case	Discourse=same_unit:46->44
18	a	a	DET	DT	Definite=Ind|PronType=Art	22	det	22:det	Entity=(abstract-82
19	novel	novel	ADJ	JJ	Degree=Pos	22	amod	22:amod	_
20	and	and	CCONJ	CC	_	21	cc	21:cc	_
21	alternative	alternative	ADJ	JJ	Degree=Pos	19	conj	19:conj:and|22:amod	_
22	method	method	NOUN	NN	Number=Sing	9	obl	9:obl:as	_
23	for	for	ADP	IN	_	27	case	27:case	_
24	other	other	ADJ	JJ	Degree=Pos	27	amod	27:amod	Entity=(abstract-83
25	colloidal	colloidal	ADJ	JJ	Degree=Pos	27	amod	27:amod	_
26	dispersion	dispersion	NOUN	NN	Number=Sing	27	compound	27:compound	Entity=(abstract-84)
27	carriers	carry	NOUN	NNS	Number=Plur	22	nmod	22:nmod:for	Entity=abstract-82)abstract-83)|SpaceAfter=No
28	.	.	PUNCT	.	_	9	punct	9:punct	_

# sent_id = AMALGUM_academic_carbamazepine-21
# s_type = decl
# text = The study aimed to prepare CBZ-SLNs with high entrapment efficiency%, small particle size, and high anticonvulsant activity compared to free CBZ.
1	The	the	DET	DT	Definite=Def|PronType=Art	2	det	2:det	Discourse=elaboration:47->40|Entity=(abstract-80
2	study	study	NOUN	NN	Number=Sing	3	nsubj	3:nsubj|5:nsubj:xsubj	Entity=abstract-80)
3	aimed	aim	VERB	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	0	root	0:root	_
4	to	to	PART	TO	_	5	mark	5:mark	_
5	prepare	prepare	VERB	VB	VerbForm=Inf	3	xcomp	3:xcomp	_
6	CBZ-SLNs	CBz-SLNs	PROPN	NNPS	Number=Plur	5	obj	5:obj	Entity=(abstract-81)
7	with	with	ADP	IN	_	11	case	11:case	_
8	high	high	ADJ	JJ	Degree=Pos	11	amod	11:amod	Entity=(abstract-30
9	entrapment	entrapment	NOUN	NN	Number=Sing	10	compound	10:compound	Entity=(abstract-85(abstract-86)
10	efficiency	efficiency	NOUN	NN	Number=Sing	11	compound	11:compound	Entity=abstract-85)|SpaceAfter=No
11	%	%	SYM	NN	Number=Sing	5	obl	5:obl:with	Entity=abstract-30)|SpaceAfter=No
12	,	,	PUNCT	,	_	15	punct	15:punct	_
13	small	small	ADJ	JJ	Degree=Pos	15	amod	15:amod	Entity=(abstract-63
14	particle	particle	NOUN	NN	Number=Sing	15	compound	15:compound	Entity=(object-87)
15	size	size	NOUN	NN	Number=Sing	11	conj	5:obl:with|11:conj:and	Entity=abstract-63)|SpaceAfter=No
16	,	,	PUNCT	,	_	20	punct	20:punct	_
17	and	and	CCONJ	CC	_	20	cc	20:cc	_
18	high	high	ADJ	JJ	Degree=Pos	20	amod	20:amod	Entity=(abstract-88
19	anticonvulsant	anticonvulsant	ADJ	JJ	Degree=Pos	20	amod	20:amod	_
20	activity	activity	NOUN	NN	Number=Sing	11	conj	5:obl:with|11:conj:and	_
21	compared	compare	VERB	VBN	Tense=Past|VerbForm=Part	20	acl	20:acl	_
22	to	to	ADP	IN	_	24	case	24:case	_
23	free	free	ADJ	JJ	Degree=Pos	24	amod	24:amod	Entity=(abstract-44
24	CBZ	CBZ	PROPN	NNP	Number=Sing	21	obl	21:obl:to	Entity=abstract-88)abstract-44)|SpaceAfter=No
25	.	.	PUNCT	.	_	3	punct	3:punct	_

